RJA
NEOS

Raymond James & Associates’s Neos Therapeutics, Inc NEOS Stock Holding History

Raymond James & Associates’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,500
Closed -$7K – 4164
2020
Q4 		$7K Hold
10,500
– – ﹤0.01% 3737
2020
Q3 		$6K Hold
10,500
– – ﹤0.01% 3557
2020
Q2 		$7K Hold
10,500
– – ﹤0.01% 3493
2020
Q1 		$8K Hold
10,500
– – ﹤0.01% 3454
2019
Q4 		$16K Hold
10,500
– – ﹤0.01% 3624
2019
Q3 		$16K Hold
10,500
– – ﹤0.01% 3549
2019
Q2 		$14K Buy
+10,500
New +$19.3K ﹤0.01% 3572

Raymond James & Associates's NEOS Position: Q1 2021 in Review

Raymond James & Associates sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 10,500 shares — an estimated $7K sold.

Raymond James & Associates first reported a position in NEOS in Q2 2019 and held it in 7 quarters. The position peaked at $16K in Q4 2019. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

  • Raymond James & Associates reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
  • Raymond James & Associates sold 10,500 Neos Therapeutics, Inc shares in Q1 2021, an estimated $7K.
  • Raymond James & Associates first reported a position in Neos Therapeutics, Inc in Q2 2019 and held it in 7 quarters.
  • Raymond James & Associates's Neos Therapeutics, Inc position peaked at $16K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Raymond James & Associates's 13F filing for Q1 2021, filed 14 May 2021.